A House Natural Resources subcommittee heard from witnesses last week calling for special tax breaks and for Congress to consider restrictions on copper scraps exports.
The Bureau of Economic Analysis released its monthly trade data for March, and despite it being the first full month of the imbroglio in the Strait of Hormuz, imports rose more than exports and the deficit surpassed the three month moving average.
How did China become a near peer competitor with the U.S. on everything from computers to AI platforms to space? Theft and IP violations.
Leadership of the House Select Committee on the CCP is convinced China is stealing American AI models. That’s why China has an OpenAI rival, called DeepSeek, and the Europeans have nothing.
The war in Iran is solar power’s Covid moment.
China holds a rapidly expanding position in the global biologics and biosimilars market, driven by heavy government support, regulatory reforms, and massive investments in biotech hubs like Shanghai and Suzhou.
If there is one Washington, D.C.-based organization that is outspoken against the positions of CPA, it’s the Tax Foundation. They have been instrumental in getting many legislators to believe tariffs would be a “tax” upwards of $1,000 per household.
Project Vault was developed to lend money to miners and entice investment in metals processing in order to build a strategic reserve of critical minerals to protect industry from supply shocks and price volatility.
Last November, the White House released its National Security Strategy of the United States that laid out the Trump administration’s strategy for the Americas. In it, the strategy imperative for the region said that one of Washington’s key goals was to make sure the Americas remains “free of hostile foreign incursion or ownership of key assets,” and was supportive of U.S. access to critical supply chains. China wasn’t mentioned by name as the hostile adversary, but China is precisely who the White House had in mind.
Everyone agrees, in particular that reliance on China for key ingredients used to make medicines is risky; and everyone agrees that further up market – in advanced biotech – China is becoming an unmatched rival that could easily shrink America’s role in drug innovation.
